CHELSEA LISK: Open Payments
NPI 1376188425 · YOUNGSTOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,046 in 44 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,046
Food & beverage: $988Education: $59
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 6 | $226 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $154 |
| Travere Therapeutics, Inc. | 3 | $89 |
| Otsuka America Pharmaceutical, Inc. | 4 | $74 |
| SCPHARMACEUTICALS INC. | 3 | $63 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| Mallinckrodt Hospital Products Inc. | 2 | $61 |
| OPKO Pharmaceuticals, LLC | 3 | $59 |
| Novo Nordisk Inc | 2 | $49 |
| Ardelyx, Inc. | 2 | $44 |
Products named: TARPEYO, Kerendia, FUROSCIX, Fabhalta, ACTHAR, RAYALDEE, JYNARQUE, Rybelsus.
Industry payments across OH — which companies pay providers there.
